Advancing Evidence-Based Treatments

To expand therapy options, availability, and access, FDA is:

• Expanding availability and access to evidence-based treatments for substance use disorders
• Facilitating development of treatments for substance use disorders, with focus on stimulant use disorder
• Facilitating opportunities to incorporate stakeholder engagement into treatment development

United States Government Partners

• Department of Health & Human Services (HHS)
• Centers for Disease Control and Prevention (CDC)
• Centers for Medicare & Medicaid Services (CMS)
• Drug Enforcement Administration (DEA)
• National Institutes of Health (NIH)
• Substance Abuse and Mental Health Services Administration (SAMHSA)
• Indian Health Service (IHS)
• Veterans Affairs (VA)

---

FDA Activities

• Prescribe with Confidence Campaign
• Medications for Opioid Use Disorder (MOUD)
• FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders
• FDA Takes Steps to Facilitate Innovation for Devices Intended to Treat Opioid Use Disorder
• FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder